Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Nov;35(11):1593–1598. doi: 10.1136/gut.35.11.1593

Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

T Minami 1, H Tojo 1, Y Shinomura 1, Y Matsuzawa 1, M Okamoto 1
PMCID: PMC1375618  PMID: 7828979

Abstract

The immunochemical protein content of group II phospholipase A2 (PLA2) and PLA2 enzymatic activity were measured for colonic mucosal biopsy samples obtained from patients with either Crohn's disease of the colon or ulcerative colitis, and control patients without inflammatory bowel disease. Immunoreactive group II PLA2 (IR-PLA2 II) content and PLA2 activity in actively inflamed colonic mucosa of Crohn's disease patients were significantly higher than those in inactively inflamed mucosa of Crohn's disease patients and the colonic mucosa of controls. IR-PLA2 II content and PLA2 activity in severely inflamed mucosa of ulcerative colitis patients were significantly higher than those in the colonic mucosa of the controls. Mucosal PLA2 enzymatic activity was closely correlated with mucosal IR-PLA2 II content in patients with Crohn's disease and ulcerative colitis. These results suggest that an increase in PLA2 enzymatic activity in inflamed colonic mucosa of Crohn's disease and ulcerative colitis was mainly attributed to increased protein content of group II PLA2, and that an increase in mucosal group II PLA2 may be involved in the pathogenesis of intestinal inflammation of Crohn's disease and ulcerative colitis.

Full text

PDF
1593

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almer S., Franzén L., Olaison G., Smedh K., Ström M. Phospholipase A2 activity of colonic mucosa in patients with ulcerative colitis. Digestion. 1991;50(3-4):135–141. doi: 10.1159/000200753. [DOI] [PubMed] [Google Scholar]
  2. Brynskov J., Tvede N., Andersen C. B., Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut. 1992 Jan;33(1):55–58. doi: 10.1136/gut.33.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chang J., Gilman S. C., Lewis A. J. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol. 1986 Feb 15;136(4):1283–1287. [PubMed] [Google Scholar]
  4. Crowl R. M., Stoller T. J., Conroy R. R., Stoner C. R. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem. 1991 Feb 5;266(4):2647–2651. [PubMed] [Google Scholar]
  5. Grönroos J. M., Nevalainen T. J. Increased concentrations of synovial-type phospholipase A2 in serum and pulmonary and renal complications in acute pancreatitis. Digestion. 1992;52(3-4):232–236. doi: 10.1159/000200958. [DOI] [PubMed] [Google Scholar]
  6. Kanda A., Ono T., Yoshida N., Tojo H., Okamoto M. The primary structure of a membrane-associated phospholipase A2 from human spleen. Biochem Biophys Res Commun. 1989 Aug 30;163(1):42–48. doi: 10.1016/0006-291x(89)92096-2. [DOI] [PubMed] [Google Scholar]
  7. Kramer R. M., Hession C., Johansen B., Hayes G., McGray P., Chow E. P., Tizard R., Pepinsky R. B. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem. 1989 Apr 5;264(10):5768–5775. [PubMed] [Google Scholar]
  8. Lauritsen K., Laursen L. S., Bukhave K., Rask-Madsen J. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis. Gut. 1987 Sep;28(9):1095–1099. doi: 10.1136/gut.28.9.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lyons-Giordano B., Davis G. L., Galbraith W., Pratta M. A., Arner E. C. Interleukin-1 beta stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun. 1989 Oct 16;164(1):488–495. doi: 10.1016/0006-291x(89)91746-4. [DOI] [PubMed] [Google Scholar]
  10. MATTS S. G. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961 Oct;30:393–407. [PubMed] [Google Scholar]
  11. Matsuda Y., Ogawa M., Sakamoto K., Yamashita S., Kanda A., Kohno M., Yoshida N., Nishijima J., Murata A., Mori T. Development of a radioimmunoassay for human group-II phospholipase A2 and demonstration of postoperative elevation. Enzyme. 1991;45(4):200–208. doi: 10.1159/000468890. [DOI] [PubMed] [Google Scholar]
  12. Minami T., Tojo H., Shinomura Y., Komatsubara T., Matsuzawa Y., Okamoto M. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol. 1993 Jul;88(7):1076–1080. [PubMed] [Google Scholar]
  13. Minami T., Tojo H., Shinomura Y., Matsuzawa Y., Okamoto M. Purification and characterization of a phospholipase A2 from human ileal mucosa. Biochim Biophys Acta. 1993 Oct 13;1170(2):125–130. [PubMed] [Google Scholar]
  14. Minami T., Tojo H., Shinomura Y., Tarui S., Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut. 1992 Jul;33(7):914–921. doi: 10.1136/gut.33.7.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murakami M., Kudo I., Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem. 1993 Jan 15;268(2):839–844. [PubMed] [Google Scholar]
  16. Nevalainen T. J., Märki F., Kortesuo P. T., Grütter M. G., Di Marco S., Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol. 1993 Feb;20(2):325–330. [PubMed] [Google Scholar]
  17. Olaison G., Leandersson P., Sjödahl R., Tagesson C. Increase in permeability and phospholipase A2 activity of colonic mucosa in Crohn's colitis. Digestion. 1989;43(4):228–233. doi: 10.1159/000199881. [DOI] [PubMed] [Google Scholar]
  18. Olaison G., Sjödahl R., Tagesson C. Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease. Digestion. 1988;41(3):136–141. doi: 10.1159/000199765. [DOI] [PubMed] [Google Scholar]
  19. Ono T., Tojo H., Kuramitsu S., Kagamiyama H., Okamoto M. Purification and characterization of a membrane-associated phospholipase A2 from rat spleen. Its comparison with a cytosolic phospholipase A2 S-1. J Biol Chem. 1988 Apr 25;263(12):5732–5738. [PubMed] [Google Scholar]
  20. Pruzanski W., Keystone E. C., Sternby B., Bombardier C., Snow K. M., Vadas P. Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol. 1988 Sep;15(9):1351–1355. [PubMed] [Google Scholar]
  21. Pruzanski W., Scott K., Smith G., Rajkovic I., Stefanski E., Vadas P. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Inflammation. 1992 Oct;16(5):451–457. doi: 10.1007/BF00918971. [DOI] [PubMed] [Google Scholar]
  22. Sharon P., Stenson W. F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology. 1984 Mar;86(3):453–460. [PubMed] [Google Scholar]
  23. Smith G. M., Ward R. L., McGuigan L., Rajkovic I. A., Scott K. F. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol. 1992 Mar;31(3):175–178. doi: 10.1093/rheumatology/31.3.175. [DOI] [PubMed] [Google Scholar]
  24. Tojo H., Ono T., Kuramitsu S., Kagamiyama H., Okamoto M. A phospholipase A2 in the supernatant fraction of rat spleen. Its similarity to rat pancreatic phospholipase A2. J Biol Chem. 1988 Apr 25;263(12):5724–5731. [PubMed] [Google Scholar]
  25. Tojo H., Ono T., Okamoto M. A pancreatic-type phospholipase A2 in rat gastric mucosa. Biochem Biophys Res Commun. 1988 Mar 30;151(3):1188–1193. doi: 10.1016/s0006-291x(88)80491-1. [DOI] [PubMed] [Google Scholar]
  26. Tojo H., Ono T., Okamoto M. Reverse-phase high-performance liquid chromatographic assay of phospholipases: application of spectrophotometric detection to rat phospholipase A2 isozymes. J Lipid Res. 1993 May;34(5):837–844. [PubMed] [Google Scholar]
  27. Vadas P. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med. 1984 Dec;104(6):873–881. [PubMed] [Google Scholar]
  28. Vadas P., Pruzanski W., Kim J., Fornasier V. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol. 1989 Apr;134(4):807–811. [PMC free article] [PubMed] [Google Scholar]
  29. Vadas P., Pruzanski W. Role of secretory phospholipases A2 in the pathobiology of disease. Lab Invest. 1986 Oct;55(4):391–404. [PubMed] [Google Scholar]
  30. Vadas P., Scott K., Smith G., Rajkovic I., Stefanski E., Schouten B. D., Singh R., Pruzanski W. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci. 1992;50(11):807–811. doi: 10.1016/0024-3205(92)90186-s. [DOI] [PubMed] [Google Scholar]
  31. Zifroni A., Treves A. J., Sachar D. B., Rachmilewitz D. Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut. 1983 Jul;24(7):659–664. doi: 10.1136/gut.24.7.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta. 1980 Sep 30;604(2):191–246. doi: 10.1016/0005-2736(80)90574-x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES